Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

haemophilus b conjugate vaccine

haemophilus b conjugate vaccine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
PedvaxHIB (PRP-OMP) INJECTION, INJECTABLE    
ActHIB (PRP-T) POWDER FOR INJECTION, INTRAMUSCULAR -    
Hiberix (PRP-T) POWDER FOR INJECTION, INTRAMUSCULAR -      

VIEW MORE Vaccines
CLASS
801200

Comments:

HIBERIX is the inpatient formulary product and can be used for both the primary vaccination dose series and the booster dose.

 

ActHIB is classified as NON-FORMULARY.

 

HIBERIX (GSK) or PEDVAXHIB (Merck) may be ordered for outpatient clinic stock.

 

HIBERIX Reviewed: November 17, 2009

Updated: June 22, 2018 (GSK Contract)


Last updated: Jul. 24, 2019







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.